MedPath

NOVARTIS (BANGLADESH) LIMITED

🇧🇩Bangladesh
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

NMPA:8
PHILIPPINES:1

Drug Approvals

Risperidone Tablets

Product Name
利培酮片
Approval Number
国药准字J20171092
Approval Date
Apr 11, 2019
NMPA

Risperidone Tablets

Product Name
利培酮片
Approval Number
J20171092
Approval Date
Apr 11, 2019
NMPA

Risperidone Tablets

Product Name
利培酮片
Approval Number
H20171056
Approval Date
Mar 6, 2019
NMPA

Mirtazapine Tablets

Product Name
米氮平片
Approval Number
国药准字J20140004
Approval Date
Jul 30, 2018
NMPA

Risperidone Tablets

Product Name
利培酮片
Approval Number
J20171091
Approval Date
Dec 20, 2017
NMPA

Risperidone Tablets

Product Name
利培酮片
Approval Number
国药准字J20171091
Approval Date
Dec 20, 2017
NMPA

Risperidone Tablets

Product Name
利培酮片
Approval Number
H20171055
Approval Date
Jul 12, 2017
NMPA

Risperidone Tablets

Product Name
利培酮片
Approval Number
H20171054
Approval Date
Jul 12, 2017
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.